363 related articles for article (PubMed ID: 26233232)
21. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
22. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
23. Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know.
Hasner MC; van Opijnen MP; van der Meulen M; Verdijk RM; Maas SLN; Te Boome LCJ; Broekman MLD
Acta Neurochir (Wien); 2024 Jun; 166(1):261. PubMed ID: 38858236
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 1p and 19q deletions in glioblastoma multiforme.
Kaneshiro D; Kobayashi T; Chao ST; Suh J; Prayson RA
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):512-6. PubMed ID: 19602970
[TBL] [Abstract][Full Text] [Related]
25. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.
Deutsch MB; Mendez MF
Cogn Behav Neurol; 2015 Mar; 28(1):1-10. PubMed ID: 25812125
[TBL] [Abstract][Full Text] [Related]
26. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
27. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.
Suh CH; Kim HS; Lee SS; Kim N; Yoon HM; Choi CG; Kim SJ
Radiology; 2014 Aug; 272(2):504-13. PubMed ID: 24697149
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of dual isotope
Osawa S; Tosaka M; Horiguchi K; Tokue A; Higuchi T; Tsushima Y; Yoshimoto Y
Int J Clin Oncol; 2022 Aug; 27(8):1264-1272. PubMed ID: 35554754
[TBL] [Abstract][Full Text] [Related]
29. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
30. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.
Barrantes-Freer A; Engel AS; Rodríguez-Villagra OA; Winkler A; Bergmann M; Mawrin C; Kuempfel T; Pellkofer H; Metz I; Bleckmann A; Hernández-Durán S; Schippling S; Rushing EJ; Frank S; Glatzel M; Matschke J; Hartmann C; Reifenberger G; Müller W; Schildhaus HU; Brück W; Stadelmann C
Brain Pathol; 2018 Mar; 28(2):225-233. PubMed ID: 28213912
[TBL] [Abstract][Full Text] [Related]
33. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
34. Neuroimaging of primary central nervous system lymphoma in immunocompetent patients: comparison of recent and previous findings.
Adachi K; Yamaguchi F; Node Y; Kobayashi S; Takagi R; Teramoto A
J Nippon Med Sch; 2013; 80(3):174-83. PubMed ID: 23832401
[TBL] [Abstract][Full Text] [Related]
35. [The clinical analysis of primary central nervous system lymphoma in 23 patients].
Piao YZ; Li P; Liu Q; Li WL
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130
[TBL] [Abstract][Full Text] [Related]
36. Primary lymphoma of the central nervous system--a diagnostic challenge.
Deckert M; Brunn A; Montesinos-Rongen M; Terreni MR; Ponzoni M
Hematol Oncol; 2014 Jun; 32(2):57-67. PubMed ID: 23949943
[TBL] [Abstract][Full Text] [Related]
37. Normal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors.
Thaler PB; Li JY; Isakov Y; Black KS; Schulder M; Demopoulos A
J Clin Neurosci; 2012 Mar; 19(3):411-4. PubMed ID: 22277560
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic Diagnosis Using 5-Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma.
Yamamoto T; Ishikawa E; Miki S; Sakamoto N; Zaboronok A; Matsuda M; Akutsu H; Nakai K; Tsuruta W; Matsumura A
Photochem Photobiol; 2015 Nov; 91(6):1452-7. PubMed ID: 26277101
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Evaluation in Primary CNS Lymphoma.
Lukas RV; Riedell P; Horowitz PM; Pytel P; Kamson DO
Neurologist; 2018 Mar; 23(2):53-54. PubMed ID: 29494436
[TBL] [Abstract][Full Text] [Related]
40. Comparison of time taken from initial presentation to histological diagnosis of Glioblastoma Multiforme (GBM) in Birmingham, United Kingdom and Strasbourg, France.
Natalwala A; Bharkhada V; Noel G; Cruickshank G
Clin Neurol Neurosurg; 2011 Jun; 113(5):358-61. PubMed ID: 21470768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
